Opportunity
Simpler Grants.gov #RFA-RM-27-002
NIH Director’s New Innovator Award for High-Risk, High-Reward Biomedical Research
Buyer
National Institutes of Health
Posted
June 26, 2026
Respond By
August 17, 2026
Identifier
RFA-RM-27-002
NAICS
541715, 541714
The National Institutes of Health (NIH) is seeking applications for the Director's New Innovator Award, supporting high-risk, high-reward biomedical research: - Government Buyer: - National Institutes of Health (NIH), under the NIH Common Fund - OEMs and Vendors: - No specific OEMs or vendors are named, as this is a grant opportunity for research projects - Products/Services Requested: - Funding for innovative biomedical research projects led by early-stage investigators - Projects may include basic, translational, or clinical research - Approximately 30 awards expected, each at $475,000 - Unique or Notable Requirements: - Open to a wide range of applicants: government, nonprofit, educational, and business entities - Foreign organizations are not eligible, but foreign components of U.S. organizations are allowed - Focus on exceptional creativity and bold, innovative research proposals - Estimated total funding pool: $23,000,000
Description
The NIH Director's New Innovator Award supports early-stage investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. Applications in any area within the biomedical sciences are welcome, including basic, translational, or clinical research. The award is part of the High-Risk, High-Reward Research program of the NIH Common Fund and complements other NIH efforts to fund early-stage investigators. The total funding available is $23,000,000 with expected awards of 30, each with a minimum and maximum award amount of $475,000. The funding instrument is a grant and the opportunity category is discretionary.